Literature DB >> 15735577

Do microbes have a causal role in type 1 diabetes?

Niina Lammi1, Marjatta Karvonen, Jaakko Tuomilehto.   

Abstract

Type 1 diabetes mellitus (T1DM) results from environmental factors acting on genetically susceptible individuals. Microbial infections and their immunological consequences are suspected to take part in the pathogenesis of T1DM. Congenital rubella infection has been strongly associated with increased disease susceptibility. In addition, infections with different strains of enteroviruses, human cytomegalovirus, and rotavirus have been suggested to be diabetogenic in susceptible individuals. A newly emerged hypothesis states that a bacterial toxin, bafilomycin A1 produced by Streptomyces spp, could be the cause of pancreatic beta-cell damage. In some instances, microbial infections may even protect the individual from T1DM. There are several proposed mechanisms of beta-cell damage caused by microbes. T1DM can result from direct cytolysis of beta-cells. Other suggested mechanisms are cross-reactivity between microbial proteins and self antigens (molecular mimicry), bystander activation of lymphocytes, and alterations in cytokine concentrations affecting T-helper cell balance in the vicinity of pancreatic beta-cells. Proving a causal role between microbial infections and T1DM appears difficult. Despite intensive research, a final conclusion concerning the causal role of microbes in the pathogenesis of T1DM has not been made.

Entities:  

Mesh:

Year:  2005        PMID: 15735577

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  22 in total

Review 1.  The Sardinian way to type 1 diabetes.

Authors:  Marco Songini; Cira Lombardo
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 2.  Environmental factors in the development of Type 1 diabetes.

Authors:  Hui Peng; William Hagopian
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

3.  Genes mediating environment interactions in type 1 diabetes.

Authors:  Erik Biros; Margaret A Jordan; Alan G Baxter
Journal:  Rev Diabet Stud       Date:  2006-02-10

4.  Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetes.

Authors:  M Mäkelä; V Oling; J Marttila; M Waris; M Knip; O Simell; J Ilonen
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 5.  Antibiotics, gut microbiota, environment in early life and type 1 diabetes.

Authors:  Youjia Hu; F Susan Wong; Li Wen
Journal:  Pharmacol Res       Date:  2017-02-07       Impact factor: 7.658

6.  Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice.

Authors:  Kelly D McCall; Jean R Thuma; Maria C Courreges; Fabian Benencia; Calvin B L James; Ramiro Malgor; Noriko Kantake; William Mudd; Nathan Denlinger; Bret Nolan; Li Wen; Frank L Schwartz
Journal:  Endocrinology       Date:  2014-11-25       Impact factor: 4.736

7.  Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside.

Authors:  Damien Bresson; Matthias von Herrath
Journal:  Diabetes Care       Date:  2009-10       Impact factor: 17.152

8.  Approaches in type 1 diabetes research: A status report.

Authors:  Oindrila Raha; Subhankar Chowdhury; Samir Dasgupta; P Raychaudhuri; B N Sarkar; P Veer Raju; V R Rao
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

9.  Mycobacterium avium subsp. paratuberculosis as a trigger of type-1 diabetes: destination Sardinia, or beyond?

Authors:  Pittu Sandhya Rani; Leonardo A Sechi; Niyaz Ahmed
Journal:  Gut Pathog       Date:  2010-03-29       Impact factor: 4.181

10.  Sequential changes in serum cytokines reflect viral RNA kinetics in target organs of a coxsackievirus B infection in mice.

Authors:  Magnus Lundgren; Per Ola Darnerud; Jonas Blomberg; Göran Friman; Nils-Gunnar Ilbäck
Journal:  J Clin Immunol       Date:  2009-05-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.